| scholarly article | Q13442814 |
| P2093 | author name string | A H Bardy | |
| P2860 | cites work | Getting to grips with Archie Cochrane's agenda | Q24679605 |
| Whose data are they anyway? | Q28754781 | ||
| Publication bias in clinical research | Q29541186 | ||
| Discrepancies between meta-analyses and subsequent large randomized, controlled trials | Q34436046 | ||
| Publication: an ethical imperative | Q36903616 | ||
| Underreporting research is scientific misconduct | Q38050046 | ||
| Growing pains of meta-analysis | Q43189788 | ||
| Incorporating variations in the quality of individual randomized trials into meta-analysis. | Q52861603 | ||
| Publication bias: its implications for clinical pharmacology | Q68018488 | ||
| Report bias in drug research | Q71857064 | ||
| Data-proof practice | Q72659845 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bias | Q742736 |
| P304 | page(s) | 147-150 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | British Journal of Clinical Pharmacology | Q176044 |
| P1476 | title | Bias in reporting clinical trials | |
| P478 | volume | 46 |
| Q38877106 | An increasing problem in publication ethics: Publication bias and editors' role in avoiding it. |
| Q36367067 | Barriers towards the publication of academic drug trials. Follow-up of trials approved by the Danish Medicines Agency |
| Q55970050 | Bias in peer review |
| Q24235035 | Comparison of protocols and registry entries to published reports for randomised controlled trials |
| Q30920608 | Extent of publication bias in different categories of research cohorts: a meta-analysis of empirical studies |
| Q52905898 | Freedom of information. |
| Q37092317 | Gap in publication of comparative information on new medicines |
| Q34300884 | Industry sponsorship and authorship of clinical trials over 20 years |
| Q28555016 | Non-Publication Is Common among Phase 1, Single-Center, Not Prospectively Registered, or Early Terminated Clinical Drug Trials |
| Q35844255 | Occurrence and determinants of selective reporting of clinical drug trials: design of an inception cohort study |
| Q38246840 | Positive Results Bias and Impact Factor in Ophthalmology |
| Q24241884 | Publication bias in clinical trials due to statistical significance or direction of trial results |
| Q50672929 | Publication bias in presentations to the Annual Scientific Congress. |
| Q90160217 | Publication language and the estimate of treatment effects of physical therapy on balance and postural control after stroke in meta-analyses of randomised controlled trials |
| Q24718169 | Publication of NIH funded trials registered in ClinicalTrials.gov: cross sectional analysis |
| Q21203744 | Reporting bias in medical research - a narrative review |
| Q24815381 | Research ethics committees: agents of research policy? |
| Q31030974 | Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews |
| Q29619094 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias |
| Q26851424 | Systematic review of the empirical evidence of study publication bias and outcome reporting bias - an updated review |
| Q34536394 | The quality and characteristics of clinical drug study notifications reviewed by the regulatory agency in Finland |
| Q42940808 | The relation between publication bias and clinical trials funding |
| Q24245587 | Time to publication for results of clinical trials |
| Q28476002 | Trial publication after registration in ClinicalTrials.Gov: a cross-sectional analysis |
| Q33890813 | Value of drug-licensing documents in studying the effect of postmenopausal hormone therapy on cardiovascular disease |
| Q29649956 | What is open peer review? A systematic review |
| Q52929780 | [Declaring conflict of interest in scientific publications. Time for the spotlights and stenographers in the backroom of research financed by the industry?]. |
| Q52885903 | [GRADE guidelines: 5. Rating the quality of evidence: publication bias]. |
Search more.